Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Julphar
UBS
Baxter
Healthtrust
Harvard Business School
Citi
Cerilliant
Cantor Fitzgerald
Fish and Richardson
McKinsey

Generated: August 17, 2017

DrugPatentWatch Database Preview

Claims for Patent: ► Subscribe

« Back to Dashboard

Claims for Patent: ► Subscribe

Title: Compositions for a once day treatment of cyclooxygenase-2 mediated diseases
Abstract:This application relates to a method of treating a disease susceptible to treatment with a non-steroidal anti-inflammatory drug by administering to a patient once daily an effective amount of 3-phenyl-4-(4-methylsulfonyl)phenyl)-2-(5H)-furanone.
Inventor(s): Hancock; Bruno (Beaconsfield, CA), Winters; Conrad (L'Ile Bizard, CA), Gertz; Barry (Summit, NJ), Ehrich; Elliot (Chatham, NJ)
Assignee: Merck & Co., Inc. (Rahway, NJ) Merch Frosst Canada & Co. (Kirkland, CA)
Application Number:09/180,647
Patent Claims: 1. A method of treating a disease susceptible to treatment with an non-steroidal anti-inflammatory agent comprising:

administration orally once a day to a human patient in need of such treatment 12.5 or 25 or 50 mg of 3-phenyl-4-(4-methylsulfonyl)phenyl)-2-(5H)-furanone.

2. A method according to claim 1 for the treatment of non-chronic headache, pain or swelling.

3. A method according to claim 1 for the treatment of osteoarthritis.

4. A method according to claim 1 for the treatment of rheumatoid arthritis.

5. A method according to claim 1 for the treatment of pain.

6. A method according to claim 1 for the treatment of fever.

7. A method according to claim 1 for the treatment of dysmenorrhea.

8. A method according to claim 1 for the treatment of Alzheimer's disease.
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Cerilliant
Harvard Business School
Medtronic
Boehringer Ingelheim
AstraZeneca
US Department of Justice
Daiichi Sankyo
Healthtrust
Novartis
Federal Trade Commission

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot